| Independent Reports (Showing 1 to 10 of 27) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 9-Feb-10 | New Constructs, LLC | N/A | FVE: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 | $10 | View Abstract |
| 9-Feb-10 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for HOSPITALS | 18 | $49 | View Abstract |
| 8-Feb-10 | Pechala's Reports | Lubomir Pechala | FIVE STAR QUALITY CARE INC (FVE=US) - REPORT FOR ACTIVE TRADERS | 4 | $25 | View Abstract |
| 8-Feb-10 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for FVE | 13 | $25 | View Abstract |
| 8-Feb-10 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | View Abstract |
| 8-Feb-10 | PriceTarget Research, Inc. | N/A | FVE has a current Overall Rating of A (Highest Rating). | 7 | $25 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) | 144 | $169 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 100 | $169 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 98 | $169 | View Abstract |
| 7-Feb-10 | Pechala's Reports | Frantisek Pechala | FIVE STAR QUALITY CARE INC (FVE=US) 12-months forecast | 1 | $15 | View Abstract |